{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1111.115","meta":{"versionId":"7","lastUpdated":"2015-11-05T01:00:01.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.115","version":"20151105","name":"Tobacco Use Cessation Pharmacotherapy Ingredient Specific","status":"active","date":"2015-11-05T01:00:01-05:00","publisher":"TJC EH Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1551467","display":"Bupropion / Naltrexone"},{"code":"203204","display":"Bupropion Hydrochloride"},{"code":"42347","display":"Bupropion"},{"code":"591622","display":"varenicline"},{"code":"636674","display":"varenicline tartrate"},{"code":"7407","display":"Nicotine"},{"code":"993548","display":"Bupropion hydrobromide"}]}]}}